Add time:08/22/2019         Source:sciencedirect.com

A series of novel dispiro piperazinyl-quinolinyl-thioxothiazolidin-2, 4-dione derivatives were synthesised and characterised by FT-IR 1H, 13C, 2D NMR and HRMS spectroscopic techniques. A representative compound 1'-(2-(4-methylpiperazin-1-yl)quinolin-3-yl)-2″-thioxo-5′,6′,7′,7a'-tetrahydro-1′H,2H-dispiro[acenaphthylene-1,3′-pyrrolizine-2′,5″-thiazolidine]-2,4″-dione was studied for its binding ability with human serum albumin (HSA) using the fluorescence quench titration method. Addition of the compound to HSA produced slight fluorescence quenching and red shift. The free energy change for the complexation process was evaluated as −29.98 kJ mol−1 thereby indicating a spontaneous and highly favourable reaction. Molecular docking analyses revealed the binding as −20.79 kJ mol−1 which was analogous with the experimental value obtained from emission data. It was concluded that TYR-263 is the moiety responsible for the binding in the complex.

We also recommend Trading Suppliers and Manufacturers of 2(1H)-Pyridinone,6-(1-piperazinyl)-(9CI) (cas 108122-24-3). Pls Click Website Link as below: cas 108122-24-3 suppliers